[HTML] cell.comFull View

[HTML][HTML] Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease

E Börgeson, AMF Johnson, YS Lee, A Till, GH Syed… - Cell metabolism, 2015 - cell.com
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA 4 (LXA 4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z …
被引用次数：211 相关文章

Lipoxin A (4) Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

E Boergeson, AMF Johnson, YS Lee, A Till… - CELL …, 2015 - koasas.kaist.ac.kr
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA (4)(LXA (4): 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z …

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

E Börgeson, AMF Johnson, YS Lee, A Till… - Cell …, 2015 - pubmed.ncbi.nlm.nih.gov
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA4 (LXA4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z, 13E …
[HTML] sciencedirect.com

[HTML][HTML] Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

E Börgeson, AMF Johnson, YS Lee, A Till, GH Syed… - Cell Metabolism, 2015 - Elsevier
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA 4 (LXA 4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z …

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.

E Börgeson, AM Johnson, YS Lee, A Till, GH Syed… - Cell …, 2015 - europepmc.org
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA 4 (LXA 4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z …
[HTML] nih.gov

[HTML][HTML] Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease

E Börgeson, AMF Johnson, YS Lee, A Till… - Cell …, 2015 - ncbi.nlm.nih.gov
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA 4 (LXA 4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z …

[引用][C] Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

E Börgeson, AMF Johnson, YS Lee, A Till, GH Syed… - Cell Metabolism, 2015 - cir.nii.ac.jp
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney
Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

E Börgeson, AMF Johnson, YS Lee, A Till… - Cell …, 2015 - scholars.uthscsa.edu
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA 4 (LXA 4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z …
[PDF] core.ac.uk

[PDF][PDF] Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

E Borgeson, AMF Johnson, YS Lee, A Till, GH Syed… - Cell Metabolism, 2015 - core.ac.uk
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA4 (LXA4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z, 13E …

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

E Börgeson, AMF Johnson, YS Lee, A Till, GH Syed… - Cell Metabolism, 2015 - infona.pl
The role of inflammation in obesity-related pathologies is well established. We investigated
the therapeutic potential of LipoxinA4 (LXA4: 5 (S), 6 (R), 15 (S)-trihydroxy-7E, 9E, 11Z, 13E …